Medium materiality5/10
Piper Sandler raises Moderna price target to $305
Why it may matterVerify against the original reporting
Bullish analyst revision with moderate implied upside; the record provides no additional supporting rationale.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Piper Sandler raised its MRNA price target to $305, roughly 12% above the posted price of $271.14.
- Target: $305
- Posted price: $271.14
- Analyst: Piper Sandler
Key facts
- 01
Target: $305
- 02
Posted price: $271.14
- 03
Analyst firm: Piper Sandler
- 04
Analyst: Edward Tenthoff
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.